Hamner, UNC launch Institute for Drug Safety Sciences - Baltimore Business Journal:

adepylex.blogspot.com
Liver toxicity is a main reason for regulatoryh agencies to deny approval for new drugs or take action againstexistint drugs. The researchers, who are working at the newlty formed Institute for DrugSafety Sciences, will use a virtual modelk of a liver to test how differentr drugs may affect the organ. The research has the potentiao to speed up the drug development andtestinb process. The Institute for Drug Safety Sciences, which opened last week and featuresea 14,000-square-foot research laboratory, will work to studgy global drug safety issues. It is being led by Paul Watkins, the Verned S. Caviness distinguished professor of medicindeat UNC.
Watkins, along with his scientist will work with members of the biomedical and pharmaceutical the U.S. Food and Drug Administration and the National Institutes of Health to develop new drugsafety initiatives. The Institute for Drug Safety Sciencez was born from an agreement signed in Aprio 2008 between UNC and Hamner to collaborate on research into drug drug development andpublic health. It is located on Hamner’sd campus in Research Triangle Park.